Lifevantage (NASDAQ:LFVN) Insider Kristen Cunningham Sells 8,901 Shares of Stock

Lifevantage Corporation (NASDAQ:LFVN) insider Kristen Cunningham sold 8,901 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $6.18, for a total transaction of $55,008.18. Following the transaction, the insider directly owned 120,162 shares in the company, valued at $742,601.16. This represents a 6.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Kristen Cunningham also recently made the following trade(s):

• On Friday, September 11th, Kristen Cunningham sold 100 shares of Lifevantage stock. The shares were sold at an average price of $6.41, for a total value of $641.00.

Lifevantage Trading Up 1.3%

NASDAQ LFVN traded up $0.08 during midday trading on Monday, hitting $6.25. The company had a trading volume of 41,083 shares, compared to its average volume of 258,840. The company has a market capitalization of $78.31 million, a PE ratio of 15.62 and a beta of 0.73. The firm has a 50-day moving average price of $6.41 and a 200-day moving average price of $5.94. Lifevantage Corporation has a twelve month low of $3.90 and a twelve month high of $11.71.

Lifevantage (NASDAQ:LFVN) last released its earnings results on Thursday, August 27th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.01). Lifevantage had a return on equity of 21.56% and a net margin of 2.78%.The company had revenue of $42.38 million for the quarter, compared to analyst estimates of $44.00 million. On average, equities analysts anticipate that Lifevantage Corporation will post 0.39 EPS for the current year.

Lifevantage Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.05 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.20 annualized dividend and a yield of 3.2%. Lifevantage’s dividend payout ratio is presently 50.00%.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Engineers Gate Manager LP increased its position in Lifevantage by 109.7% during the 2nd quarter. Engineers Gate Manager LP now owns 27,009 shares of the company’s stock valued at $169,000 after purchasing an additional 14,131 shares during the period. Bank of New York Mellon Corp bought a new position in Lifevantage during the second quarter worth $78,000. Bank of America Corp DE grew its holdings in Lifevantage by 24.3% during the 1st quarter. Bank of America Corp DE now owns 23,445 shares of the company’s stock worth $101,000 after acquiring an additional 4,586 shares during the period. Hsbc Holdings PLC bought a new position in shares of Lifevantage in the 1st quarter worth about $51,000. Finally, DGS Capital Management LLC bought a new stake in shares of Lifevantage during the 1st quarter valued at about $44,000. 35.32% of the stock is owned by institutional investors.

Analyst Ratings Changes

LFVN has been the topic of several recent analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Lifevantage in a research note on Friday, August 21st. Lake Street Capital lifted their target price on Lifevantage from $5.00 to $6.00 and gave the company a “hold” rating in a research report on Friday, August 28th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $5.50.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.